• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姑息治疗在腹膜癌病和恶性腹水管理中的应用。

A Palliative Approach to Management of Peritoneal Carcinomatosis and Malignant Ascites.

机构信息

Division of General Surgery, Huntsman Cancer Institute, University of Utah, 1950 Circle of Hope, Suite 6405, Salt Lake City, UT 84112, USA.

Division of General Surgery, Huntsman Cancer Institute, University of Utah, 1950 Circle of Hope, Suite 6405, Salt Lake City, UT 84112, USA.

出版信息

Surg Oncol Clin N Am. 2021 Jul;30(3):475-490. doi: 10.1016/j.soc.2021.02.004.

DOI:10.1016/j.soc.2021.02.004
PMID:34053663
Abstract

In addition to severe, life-limiting complications such as malignant bowel obstruction, fistulae, and malignant ascites, peritoneal carcinomatosis frequently causes life-impacting symptoms such as pain, nausea, anorexia, cachexia, and fatigue. A variety of medical, interventional, and surgical therapies are now available for management of both complications and symptoms. Although surgery in this population is often associated with a relatively high risk of morbidity and mortality, operative intervention can offer effective palliative treatment in appropriately selected patients. Early involvement of palliative care specialists as part of a multidisciplinary team is essential to providing optimal, holistic care of patients with peritoneal carcinomatosis.

摘要

除了恶性肠梗阻、瘘管和恶性腹水等严重的生命受限并发症外,腹膜癌病还常导致严重影响生活的症状,如疼痛、恶心、厌食、恶病质和疲劳。目前有多种医疗、介入和手术治疗方法可用于治疗并发症和症状。尽管该人群的手术通常与较高的发病率和死亡率相关,但手术干预可以为适当选择的患者提供有效的姑息治疗。姑息治疗专家作为多学科团队的一部分尽早参与,对于为腹膜癌病患者提供最佳的整体护理至关重要。

相似文献

1
A Palliative Approach to Management of Peritoneal Carcinomatosis and Malignant Ascites.姑息治疗在腹膜癌病和恶性腹水管理中的应用。
Surg Oncol Clin N Am. 2021 Jul;30(3):475-490. doi: 10.1016/j.soc.2021.02.004.
2
Cervical Esophago-Gastric Tubes for Patients with Malignant Ascites.用于恶性腹水患者的颈段食管胃管
J Gastrointest Surg. 2017 Jan;21(1):199-201. doi: 10.1007/s11605-016-3211-2. Epub 2016 Jul 29.
3
Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer.非妇科癌症所致腹膜癌病患者恶性肠梗阻姑息手术的结局
Ann Surg Oncol. 2001 Sep;8(8):632-7. doi: 10.1007/s10434-001-0632-1.
4
Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review.癌性腹膜炎所致恶性肠梗阻的姑息性手术:系统评价。
JAMA Surg. 2014 Apr;149(4):383-92. doi: 10.1001/jamasurg.2013.4059.
5
Palliative Management of Advanced Peritoneal Carcinomatosis.晚期腹膜癌的姑息治疗
Surg Oncol Clin N Am. 2018 Jul;27(3):585-602. doi: 10.1016/j.soc.2018.02.008.
6
Acute malignant obstruction in patients with peritoneal carcinomatosis: The role of palliative surgery.腹膜癌病患者的急性恶性梗阻:姑息性手术的作用。
Eur J Surg Oncol. 2019 Mar;45(3):389-393. doi: 10.1016/j.ejso.2018.12.015. Epub 2018 Dec 21.
7
Management of Malignant Bowel Obstruction Associated With GI Cancers.胃肠道癌症相关恶性肠梗阻的管理
J Oncol Pract. 2017 Jul;13(7):426-434. doi: 10.1200/JOP.2017.022210.
8
Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.腹腔镜热灌注化疗(HIPEC)治疗晚期胃癌不可切除性腹膜癌病继发的恶性腹水。
Eur J Surg Oncol. 2008 Feb;34(2):154-8. doi: 10.1016/j.ejso.2007.05.015. Epub 2007 Jul 20.
9
The role of "closed abdomen" hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience.“封闭腹腔”热灌注化疗(HIPEC)在腹膜癌病所致肿瘤性腹水姑息治疗中的作用:单中心经验报告
Support Care Cancer. 2016 Oct;24(10):4293-9. doi: 10.1007/s00520-016-3262-7. Epub 2016 May 12.
10
Factors affecting successful palliative surgery for malignant bowel obstruction due to peritoneal dissemination from colorectal cancer.影响结直肠癌腹膜播散所致恶性肠梗阻姑息性手术成功的因素。
Jpn J Clin Oncol. 2003 Jul;33(7):357-9. doi: 10.1093/jjco/hyg061.

引用本文的文献

1
Bispecific antibodies: unleashing a new era in oncology treatment.双特异性抗体:开启肿瘤治疗的新时代。
Mol Cancer. 2025 Aug 4;24(1):212. doi: 10.1186/s12943-025-02390-y.
2
Research progress and treatment status of malignant ascites.恶性腹水的研究进展与治疗现状
Front Oncol. 2024 Dec 16;14:1390426. doi: 10.3389/fonc.2024.1390426. eCollection 2024.
3
Risk factors for early readmission to hospital in patients with malignancy-related ascites: a retrospective cohort study.恶性肿瘤相关性腹水患者早期再次入院的危险因素:一项回顾性队列研究。
Front Oncol. 2024 Oct 1;14:1409411. doi: 10.3389/fonc.2024.1409411. eCollection 2024.
4
Percutaneous Endoscopic Colostomy to Relieve Malignant Bowel Obstruction.经皮内镜下结肠造口术治疗恶性肠梗阻
Eur J Case Rep Intern Med. 2024 Sep 24;11(10):004872. doi: 10.12890/2024_004872. eCollection 2024.
5
The relationship between nutritional status and prognosis in advanced gastrointestinal cancer patients in palliative care: a prospective cohort study.晚期胃肠道癌姑息治疗患者营养状况与预后的关系:一项前瞻性队列研究。
Support Care Cancer. 2024 Oct 1;32(10):697. doi: 10.1007/s00520-024-08884-7.
6
Non-Coding RNAs in Peritoneal Carcinomatosis: From Bench to Bedside.腹膜癌病中的非编码RNA:从实验台到病床
Cancers (Basel). 2024 Aug 25;16(17):2961. doi: 10.3390/cancers16172961.
7
Targeting SNCA in the treatment of malignant ascites in gastrointestinal cancer.靶向α-突触核蛋白治疗胃肠道癌恶性腹水
Transl Oncol. 2024 Oct;48:102075. doi: 10.1016/j.tranon.2024.102075. Epub 2024 Aug 3.
8
Combined Intraperitoneal Paclitaxel and Systemic Chemotherapy for Patients with Massive Malignant Ascites Secondary to Pancreatic Cancer: A Report of Two Patients.腹腔内紫杉醇联合全身化疗治疗胰腺癌所致大量恶性腹水患者:两例报告。
Intern Med. 2024 Jul 15;63(14):2015-2021. doi: 10.2169/internalmedicine.2191-23. Epub 2023 Dec 4.
9
Multidisciplinary approach, continuous care and opioid management in cancer pain: case series and review of the literature.癌症疼痛的多学科方法、持续护理与阿片类药物管理:病例系列及文献综述
Drugs Context. 2023 Apr 11;12. doi: 10.7573/dic.2022-11-7. eCollection 2023.
10
Palliative Gastrointestinal Surgery in Patients With Advanced Peritoneal Carcinomatosis: Clinical Experience and Development of a Predictive Model for Surgical Outcomes.晚期腹膜癌患者的姑息性胃肠手术:临床经验及手术结局预测模型的建立
Front Oncol. 2022 Jan 13;11:811743. doi: 10.3389/fonc.2021.811743. eCollection 2021.